Market Cap

SynAct Pharma AB Market Capitalization:

€28.2 Million

EUR as of Jan. 1, 2024

US$31.1 Million

business SynAct Pharma AB Company Profile

SynAct Pharma AB Main Stock Listing

FSX: 8F8

Market Capitalization History of SynAct Pharma AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of SynAct Pharma AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 €28.2 M -87.91%
Jan. 1, 2023 €233.0 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

SynAct Pharma AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

SynAct Pharma AB has the following listings and related stock indices.


Stock: FSX: 8F8

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.